Oncolytic viruses get a boost with first FDA-approval recommendation

Elie Dolgin • June 1, 2015

The future of cancer-killing viruses lies in their potential to augment cell and antibody immunotherapies.

Continue reading here.

Girl jumping with arms bandaged
By Elie Dolgin August 27, 2025
Fresh treatments shift the focus from symptom management to repair.
By Elie Dolgin August 27, 2025
Smart algorithms take aim at antimicrobial resistance.